clinical development Applications
-
Medical solutions for vaccine platform sector
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. The particles contain no viral genome and are replicative defective and non-pathogenic. The particle capsid surface has repetitive, immunogenic sites, where peptides of interest can be inserted and allows us to generate monovalent or bivalent vaccines as required. Each peptide of interest will be presented 60 times on the capsid surface and both the innate and adaptive immune systems are activated to ...
By 2A Pharma ApS based in Aalborg Øst, DENMARK.
-
Drug Dolution for Gastric Cancer
Gastric cancer is a disease in which cancer cells form in the lining of the stomach. Almost all gastric cancers are adenocarcinomas, a cancer that begins in glandular tissue. Gastric cancer is often in an advanced stage when it is diagnosed. At this stage, it can often be treated, but rarely ...
By Ascelia Pharma AB based in Malmö, SWEDEN.
-
RTSM Solutions for Site satisfaction
Site satisfaction is a top priority at 4G Clinical. Prancer RTSM® was designed with direct ...
By 4G Clinical based in Wellesley, MASSACHUSETTS (USA).
-
Healthcare & Medical App
and arrangements. The correct clinical application development support does not just convey quicker services ...
By Moon Technolabs based in Ahmedabad, INDIA.
-
Proprietary Technologies for Approach Towards COVID-19
continuously arise, including in the Spike protein, and may further reduce clinical protection derived ...
By Gritstone Bio based in Emeryville, CALIFORNIA (USA).
-
Potential breakthrough treatment option for Critical Limb Ischemia (CLI)
is seeking partnership for further clinical development and commercialization of Stempeucel® for ...
By Stempeutics Research Pvt. Ltd. based in Bangalore, INDIA.
-
Solutions for Neuroscience
Our driving philosophy at Otsuka is to serve those with unmet medical needs, and that couldn’t be more true than in our dedication to the central nervous system (CNS) space. In our 30 years of experience working in this therapeutic area, we continue to innovate and defy limitation by taking risks to overcome the complexities of treating mental health. We respect the value within every mind and are committed to making a difference in the lives of patients living with schizophrenia, major depressive disorder, ...
By Otsuka America Pharmaceutical, Inc based in Princeton, NEW JERSEY (USA).
-
Data Annotation for Life Sciences
From accelerating drug discovery to leveraging real world evidence, Centaur Labs provides life sciences innovators with high-quality medical data annotations at unprecedented speed and ...
By Centaur Labs based in Boston, MASSACHUSETTS (USA).
-
Freeze-Dried Hemostatic for Patients
Clinical trials are a critical step in the development process of a new therapeutic like ...
By Cellphire Therapeutics, Inc. based in Rockville, MARYLAND (USA).
-
Microbiome Therapeutics for Clinical Trials
Finch’s lead candidate, CP101, is in late-stage clinical development for the ...
By Finch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA).
-
Proteome array screening solutions for antibody specificity profiling sector
Comprehensive antibody reactivity profiling: validate specificity, identify cross-reactions. The issue of antibody cross-reactivity is one that has often been often overlooked or sidelined in the past, with typical antibody QC involving evidence of binding to the intended target, while neglecting potential cross-reactivity. In recent years, however, many examples have come to light where poor validation of antibodies has led to misleading or erroneous conclusions for assays in which they are used as reagents, due ...
By Cambridge Protein Arrays Ltd. (CPAP) based in Cambridge, UNITED KINGDOM.
-
Probiotics: Pharmaceutical-Quality Innovative Solutions
The use of probiotics is a very promising alternative for the prevention and/or treatment of multiple health issues, in both humans and animals. By modifying the composition of the microbiota with probiotics, we may help to mitigate and solve upper respiratory, genitourinary or gastrointestinal tracts and periodontal infections, as well as dysbiosis issues related to fertility, premature births, dermatology, autoimmune diseases, and many more. The key is to choose the appropriate strain and dosage for each ...
By Zinereo Pharma based in Pontevedra, SPAIN.
-
RNA Technology for Product Pipeline Research
Our product pipeline shows the progress we’re making on clinical programs ...
By Moderna, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Data Annotation for Researchers
From AI innovation in emergency medicine to cardiology, Centaur Labs provides researchers on the cutting edge of their fields with high-quality medical data annotations at unprecedented speed and ...
By Centaur Labs based in Boston, MASSACHUSETTS (USA).
-
Supply Solutions for Early-Phase Planning
4C Supply leverages available information to develop an initial supply plan for IP ...
By 4G Clinical based in Wellesley, MASSACHUSETTS (USA).
-
microbiota for Clinical Studies
, including: de-risking of clinical programmes based on IMT precedence, accelerated clinical ...
By EnteroBiotix Ltd based in Glasgow, UNITED KINGDOM.
-
Micro-Invasive Glaucoma Surgery Device (MIGS) for Clinical Trial Program Supports
A comprehensive clinical trial program supports the development of MINIject®, with ...
By iSTAR Medical SA based in Wavre, BELGIUM.
-
Choline Fenofibrate
BOC Sciences is committed to supplying cost-effective products and services. We provide Choline Fenofibrate (Cas No:856676-23-8). More information, please visit the website: http://www.bocsci.com/choline-fenofibrate-cas-856676-23-8-item-84-259938.html ...
By BOC Sciences based in Shirley, NEW YORK (USA).
-
Multipotent Cell Conditioned Media Technology for HST 001 – Hair Stimulating Complex (HSC)
Histogen’s lead product application is a Hair Stimulating Complex (HSC), intended to be a physician-administered therapeutic for alopecia (hair loss). HSC is anticipated to be a safe, minimally-invasive treatment that promotes new hair growth where existing treatments only reduce hair loss. ...
By Histogen Inc. based in San Diego, CALIFORNIA (USA).
-
RTSM Solutions for Phase 2 Trials
Prancer RTSM provides the flexibility you need to explore all the possible paths for determining the optimal dose, patient population, and combination therapies within your Phase 2 ...
By 4G Clinical based in Wellesley, MASSACHUSETTS (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you